Sodium Bicarbonate
18 NDCs across 15 manufacturers|18 Generic,0 Brand
Sodium Bicarbonate is used to treat renal tubular acidosis, drug overdose, dyspepsia, gastroesophageal reflux, heart arrest and heartburn, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 3, 1986, and the first generic was approved Nov 9, 2005. In 2024, Medicare Part D spent $567K on Sodium Bicarbonate across 8,519 claims for 1,804 beneficiaries.
Sodium Bicarbonate is available as 18 NDCs from 15 manufacturers (18 generic, 0 brand), with NADAC prices from $0.15 to $0.33 per ML — the most expensive product costs about 2.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
15 Sodium Bicarbonate presentations are currently listed in FDA's drug shortage database (first posted Mar 1, 2017). Shortages can move NADAC prices in the following weeks.
Total NDCs
18
18G / 0B
Manufacturers
15
competing in market
Price Spread
$0.15 – $0.33
per ML, 11 of 18 NDCs
7d Activity
avg -0.9% WoW · of 18 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
15 manufacturers producing SODIUM BICARBONATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SODIUM BICARB 8.4% ABBOJECT | $0.3288 per ML | — |
SODIUM BICARB 8.4% SYRINGE | $0.3288 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARBONATE 8.4% VIAL | $0.1540 per ML | — |
SODIUM BICARB 325 MG TABLET | $0.0148 per EA | -1.80% |
SODIUM BICARB 650 MG TABLET | $0.0129 per EA | -0.69% |
SODIUM BICARB 650 MG TABLET | $0.0129 per EA | -0.69% |
SODIUM BICARB 650 MG TABLET | $0.0129 per EA | -0.69% |
SODIUM BICARB 650 MG TABLET | $0.0129 per EA | -0.69% |
SODIUM BICARB 650 MG TABLET | $0.0129 per EA | -0.69% |
SODIUM BICARB 10 GRAIN TABLET | $0.0113 per EA | — |
Frequently Asked Questions
What is Sodium Bicarbonate used to treat?
Sodium Bicarbonate is used to treat renal tubular acidosis, drug overdose, dyspepsia, gastroesophageal reflux, heart arrest and heartburn, per the National Library of Medicine's MED-RT classification.
When did Sodium Bicarbonate become available as a generic?
FDA approved the first generic Sodium Bicarbonate (ANDA) on Nov 9, 2005.
How much does Medicare spend on Sodium Bicarbonate?
In 2024, Medicare Part D spent $567K on Sodium Bicarbonate across 8,519 claims for 1,804 beneficiaries.
Is Sodium Bicarbonate in shortage?
Yes — FDA's drug shortage database currently lists 15 Sodium Bicarbonate presentations with status "Current", first posted Mar 1, 2017.
How many Sodium Bicarbonate products are on the market?
The Sodium Bicarbonate drug market contains 18 NDCs from 15 manufacturers — 18 generic and 0 brand products.
What is the price range for Sodium Bicarbonate?
NADAC reference prices for Sodium Bicarbonate range from $0.1540 to $0.3288 per ML — the most expensive product costs about 2.1× the cheapest. 7 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Sodium Bicarbonate?
15 manufacturers list Sodium Bicarbonate in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (3), Rugby Laboratories (2), International Medication Systems, Limited (1), Sun Pharmaceutical Industries Inc. (1), Fresenius Kabi USA, LLC (1).
How has the price of Sodium Bicarbonate changed recently?
Over the past 7 days, 0 Sodium Bicarbonate NDCs rose and 6 fell, with a market-wide average change of -0.9%.